Molecular adsorbent recirculating system (MARS)

Annals of the Academy of Medicine Singapore

Volumn 33, Issue 3, 2004, Pages 329-335

  Tan, Han Kim ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Acute liver failure; Artificial liver; Dialysis

Indexed keywords

ADSORBENT; ALBUMIN; AMMONIA; AROMATIC AMINO ACID; BILIRUBIN; FATTY ACID; LACTIC ACID;

ACUTE KIDNEY FAILURE; ALBUMIN DIALYSIS; ARTIFICIAL LIVER; ARTIFICIAL VENTILATION; BRAIN EDEMA; DEVICE; DIALYSIS; HEMOFILTRATION; HEPATIC ENCEPHALOPATHY; HOMEOSTASIS; HUMAN; INTENSIVE CARE UNIT; INTRACRANIAL HYPERTENSION; LIVER FAILURE; LIVER TRANSPLANTATION; MEDICAL LITERATURE; MULTIPLE ORGAN FAILURE; REVIEW;

EID: 3142728654     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Herrera JL. Management of acute liver failure. Dig Dis 1998;16:274-83.
2. Bathgate AJ, Hayes PC. Acute liver failure: complications and current management. Hosp Med 1998;59:195-9.
3. Colquhoun SD, Lipkin C, Connelly CA. The pathophysiology, diagnosis and management of acute hepatic encephalopathy. Adv Intern Med 2001;46:155-76.
4. Teo EK, Ostapowicz G, Hussain M, Lee WM, Fontana RJ, Lok AS. Hepatitis B infection in patients with acute liver failure in the United States. Hepatology 2001;33:972-6.
5. Newsome PN, Bathgate AJ, Henderson NC, MacGilchrist AJ, Plevris JN, Masterton G, et al. Referral patterns and social deprivation in paracetamol-induced liver injury in Scotland. Lancet 2001;358::1612-3.
6. Petrelli E, Balducci M, Pieretti C, Rocchi MB, Clementi M, Manzin A. Lamivudine treatment failure in preventing fatal outcome of de novo severe acute hepatitis B in patients with haematological diseases. J Hepatol 2001;35:823-6.
7. Bosia JD, Borzi S, Cocozzella D, Alvarado Torres R, Fraquelli E, Curciarello JO. Acute liver failure: clinical-epidemiological characteristics [Spanish]. Acta Gastroenterol Latinoam 2001;31:383-6.
8. Gill RQ, Sterling RK. Acute liver failure. J Clin Gastroenterol 2001; 33:191-8.
9. Rahman T, Hodgson H. Clinical management of acute hepatic failure. Intensive Care Med 2001;27:467-76.
10. Stockmann HB, Ijzermans JN. Prospects for the temporary treatment of acute liver failure. Eur J Gastroenterol Hepatol 2002;14:195-203.
11. de Rave S, Tilanus HW, van der Linden J, de Man RA, van der Berg B, Hop WC, et al. The importance of orthotopic liver transplantation in acute hepatic failure. Transpl Int 2002;15:29-33.
12. Hashikura Y, Kawasaki S, Miyagawa S, Terada M, Ikegami T, Nakazawa Y, et al. Recent advance in living donor liver transplantation. World J Surg 2002;26:243-6.
13. Larsen FS, Hansen BA, Blei AT. Intensive care management of patients with acute liver failure with emphasis on systemic hemodynamic instability and cerebral edema: a critical appraisal of pathophysiology. Can J Gastroenterol 2000;14:D105-11.
14. Mitzner SR, Stange J, Peszynski P, Klammt S. Extracorporeal support of the failing liver. Curr Opin Crit Care 2002;8:171-7.
15. Ash SR, Caldwell CA, Singer GG, Lowell JA, Howard TK, Rustgi VK. Treatment of acetaminophen-induced hepatitis and fulminant hepatic failure with extracorporeal sorbent-based devices. Adv Ren Replace Ther 2002;9:42-53.
16. Ash SR. Extracorporeal blood detoxification by sorbents in treatment of hepatic encephalopathy. Adv Ren Replace Ther 2002;9:3-18.
17. Steiner C, Mitzner S. Experiences with MARS liver support therapy in liver failure: analysis of 176 patients of the International MARS Registry. Liver 2002;22:20-5.
18. Larsen FS, Gottstein J, Blei AT. Cerebral hyperemia and nitric oxide synthase in rats with ammonia-induced brain edema. J Hepatol 2001;34:548-54.
19. de Knegt RJ, Groeneweg M, Schalm SW, Hekking-Weijma I. Encephalopathy from acute liver failure and from acute hyperammonemia in the rabbit. A clinical and biochemical study. Liver 1994;14:25-31.
20. Clemmesen JO, Larsen FS, Kondrup J, Hansen BA, Ott P. Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentration. Hepatology 1999;29:648-53.
21. Clemmesen JO, Hoy CE, Kondrup J, Ott P. Splanchnic metabolism of fuel substrates in acute liver failure. J Hepatol 2000;33:941-8.
22. Jalan R, Williams R. Improvement in cerebral perfusion after MARS therapy: further clues about the pathogenesis of hepatic encephalopathy? Liver Transpl 2001;7:713-5.
23. Singer AL, Olthoff KM, Kim H, Rand E, Zamir G, Shaked A. Role of plasmapheresis in the management of acute hepatic failure in children. Ann Surg 2001;234:418-24.
24. st ed. Oxford:Oxford Univ Press, 1991:923-42.
25. rd ed. Philadelphia:WB Saunders, 1996:618-50.
26. Jalan R, Olde Damink SW. Hypothermia for the management of intracranial hypertension in acute liver failure. Curr Opin Crit Care 2001;7:257-62.
27. Kierdorf HP, Leue C, Arns S. Lactate- of bicarbonate-buffered solutions in continuous extracorporeal renal replacement therapies. Kidney Int Suppl 1999;72:S32-6.
28. st ed. Oxford:Oxford Univ Press, 1991:1429-49.
29. rd ed. Philadelphia: WB Saunders, 1996:605-17.
30. Clemmesen JO, Hoy CE, Jeppesen PB, Ott P. Plasma phospholipid fatty acid pattern in severe liver disease. J Hepatol 2000;32:481-7.
31. Butterworth RF. Neurotransmitter dysfunction in hepatic encephalopathy: new approaches and new findings. Metab Brain Dis 2001;16:55-65.
32. Michalak A, Chatauret N, Butterworth RF. Evidence for a serotonin transporter deficit in experimental acute liver failure. Neurochem Int 2001;38:163-8.
33. Clemmesen JO, Larsen FS, Kondrup J, Hansen BA, Ott P. Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentration. Hepatology 1999;29:648-53.
34. Arai T, Yoshikai Y, Kamiya J, Nagino M, Uesaka K, Yuasa N, et al. Bilirubin impairs bactericidal activity of neutrophils through an antioxidant mechanism in vitro. J Surg Res 2001;96:107-13.
35. Jalan R, Williams R. Acute-on-chronic liver failure: pathophysiological basis of therapeutic options. Blood Purif 2002;20:252-61.
36. Heemann U, Treichel U, Loock J, Philipp T, Gerken G, Malago M, et al. Albumin dialysis in cirrhosis with superimposed acute liver injury: a prospective, controlled study. Hepatology 2002;36:949-58.
37. Hofmann RM, Maloney C, Ward DM, Becker BN. A novel method for regional citrate anticoagulation in continuous venovenous hemofiltration (CVVHF). Ren Fail 2002;4:325-35.
38. Hidalgo N, Hynes-Gay P, Hill S, Burry L. Anticoagulation in continuous renal replacement therapy. Dynamics 2001;12:13-7.
39. Vargas Hein O, von Heymann C, Lipps M, Ziemer S, Ronco C, Neumayer HH, et al. Hirudin versus heparin for anticoagulation in continuous renal replacement therapy. Intensive Care Med 2001;27:673-9.
40. Tan HK, Baldwin I, Bellomo R. Continuous veno-venous hemofiltration without anticoagulation in high-risk patients. Intensive Care Med 2000;26:1652-7.
41. Awad SS, Swaniker F, Magee J, Punch J, Bartlett RH. Results of a phase I trial evaluating a liver support device utilizing albumin dialysis. Surgery 2001;130:354-62.
42. Stange J, Mitzner SR, Risler T, Erley CM, Lauchart W, Goehl H, et al. Molecular adsorbent recycling system (MARS): clinical results of a new membrane-based blood purification system for bioartificial liver support. Artif Organs 1999;23:319-30.
43. Stange J, Mitzner SR, Klammt S, Freytag J, Peszynski P, Loock J, et al. Liver support by extracorporeal blood purification: a clinical observation. Liver Transpl 2000;6:603-13.
44. Sorkine P, Ben Abraham R, Szold O, Bidernmn P, Kidron A, Merchav H, et al. Role of the molecular adsorbent recycling system (MARS) in the treatment of patients with acute exacerbation of chronic liver failure. Crit Care Med 2001;29:1332-6.
45. Schmidt LE, Svendsen LB, Sorensen VR, Hansen BA, Larsen FS. Cerebral blood flow velocity increases during a single treatment with the molecular adsorbents recirculating system in patients with acute-on-chronic liver failure. Liver Transpl 2001;7:709-12.
46. Mitzner SR, Stange J, Klammt S, Risler T, Erley CM, Bader BD, et al. Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial. Liver Transpl 2000;6:277-86.
47. Kellersmann R, Gassel HJ, Buhler C, Thiede A, Timmermann W. Application of Molecular Adsorbent Recirculating System in patients with severe liver failure after hepatic resection or transplantation: initial single-centre experiences. Liver 2002;22:56-8.
48. Stange J, Hassanein TI, Mehta R, Mitzner SR, Bartlett RH. The molecular adsorbents recycling system as a liver support system based on albumin dialysis: a summary of preclinical investigations, prospective, randomized, controlled clinical trial, and clinical experience from 19 centers. Artif Organs 2002;26:103-10.
49. Gettings LG, Reynolds HN, Scalea T. Outcome in post-traumatic acute renal failure when continuous renal replacement therapy is applied early versus late. Intensive Care Med 1999;25:805-13.
50. Ronco C, Bellomo R, Homel P, Brendolan A, Dan M, Piccinni P, et al. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 2000;356:26-30.